Laboratoires Théa - About the company
Laboratoires Théa is an unfunded company based in Clermont Ferrand (France), founded in 1993. It operates as a Large private ophthalmology specialized pharma company. Laboratoires Théa has not raised any funding yet. The company has 2646 active competitors, including 906 funded and 676 that have exited. Its top competitors include companies like Jazz Pharmaceuticals, Sana Biotechnology and Ideaya Biosciences.
Company Details
Laboratoires Thea is a large, private pharma company, specialized in ophthalmology. Their expertise is in the field of preservative-free eye drops. They have successfully marketed the first intracameral antibiotic for prophylaxis of endophthalmitis in cataract surgery. They currently have one lead candidate in phase III
Key Metrics
Founded Year
1993
Location
Clermont Ferrand, France
Stage
Unfunded
Ranked
745th among 2646 active competitors
Employee Count
965 as on May 31, 2026
Investment & Acquisitions
Similar Companies
Sign up to download Laboratoires Théa's company profile
Laboratoires Théa's funding and investors
Laboratoires Théa has not raised any funding rounds yet.
Laboratoires Théa's founders and board of directors
Founder? Claim ProfileLaboratoires Théa's employee count trend
Laboratoires Théa has 965 employees as of May 26. Here is Laboratoires Théa's employee count trend over the years:
Uncover Laboratoires Théa's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Laboratoires Théa's Competitors and alternates
Top competitors of Laboratoires Théa include Jazz Pharmaceuticals, Sana Biotechnology and Ideaya Biosciences. Here is the list of Top 10 competitors of Laboratoires Théa, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Jazz Pharmaceuticals 2003, Dublin (Ireland), Public | Developer of novel biopharmaceutical medicines for unmet medical needs | $265M | 82/100 | |
2nd |  Sana Biotechnology 2018, Seattle (United States), Public | Developer of engineered cell therapies for treating various human diseases | $821M | 75/100 | |
3rd | Ideaya Biosciences 2015, San Francisco (United States), Public | Developer of oncology-focused precision medicine using molecular diagnostics | $157M | 72/100 | |
4th | Sutro Biopharma 2003, United States, Public | Developer of antibody-based therapeutics for cancer therapy | $175M | 72/100 | |
5th | Syndax 2005, Waltham (United States), Public | Developer of targeted therapies for the treatment of cancer | $198M | 72/100 | |
6th | Karyopharm 2008, Newton (United States), Public | Biopharmaceutical company focused on developing and commercializing innovative cancer therapies | $98.4M | 71/100 | |
7th | C4 Therapeutics 2016, Cambridge (United States), Public | Developer of small molecule drugs for treating cancer | $223M | 71/100 | |
8th | Developer of T-cell therapies for the treatment of cancer | $49.8M | 71/100 | ||
9th | Developer of bi-specific antibodies & antibody-drug conjugates to treat cancer | $146M | 71/100 | ||
10th | _1545299782322.png?devicePixelRatio=2&height=30&width=30){kind=logo} Erasca 2018, San Diego (United States), Public | Developer of small molecule based therapeutics for cancer | $300M | 71/100 | |
745th | Laboratoires Théa 1993, Clermont Ferrand (France), Unfunded | Large private ophthalmology specialized pharma company | - | - | 43/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Laboratoires Théa's competitors? Click here to see the top ones
Laboratoires Théa's Investments and acquisitions
Laboratoires Théa has made 2 investments in Tilak Healthcare and Ripple Therapeutics. Laboratoires Théa has not made any acquisitions as of now.Reports related to Laboratoires Théa
Here is the latest report on Laboratoires Théa's sector:
News related to Laboratoires Théa
Filter this list•
•
•
Novaliq and Laboratoires Théa announce EC approval for dry eye disease therapyPharmaceutical Technology•Oct 03, 2024•Novaliq, Laboratoires Théa
•
•
ProQR, Théa ink new $8.6M pact for eye assets after old one collapsedFierce Biotech•Dec 08, 2023•ProQR Therapeutics, Laboratoires Théa, Theapharmainc
•
The start-up Tilak Healthcare, specialist in home vision monitoring, raises 10 million eurosusine-digitale.fr•Oct 12, 2023•Tilak Healthcare, Elaia, Caphorn, Laboratoires Théa and 2 others
•
$10 million for TILAK HEALTHCARE to develop its remote monitoring solution in ophthalmologyFrenchWeb•Oct 12, 2023•Tilak Healthcare, Elaia, iBionext, SWEN Capital Partners and 1 other
•
Tilak Healthcare Raises €10 Million to Continue Growing Its Leading Ophthalmological Telemedicine OfferingBusiness Wire•Oct 12, 2023•Elaia, Tilak Healthcare, Caphorn, iBionext and 3 others
•
Tilak Healthcare Raises €10M in FundingFinSMEs•Oct 12, 2023•Tilak Healthcare, Elaia, iBionext, SWEN Capital Partners and 1 other
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Laboratoires Théa
Explore our recently published companies
- Saalfo Tech - Mysuru based, 1990 founded, Unfunded company
- Tolia - Thane based, 1979 founded, Unfunded company
- Uvtcpl - India based, Unfunded company
- Diamondexch99 - Unfunded company
- Krishna's Herbal & Ayurveda - Jodhpur based, 2007 founded, Funding Raised company
- Dash - Atlanta based, 2025 founded, Unfunded company
